MARY KEEGAN: Open Payments
NPI 1336157213 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$206 in 12 payments from 8 companies in 2025. Trend: 2023 $91 · 2024 $439 · 2025 $206
Food & beverage: $206
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 2 | $32 |
| Amgen Inc. | 2 | $32 |
| Novartis Pharmaceuticals Corporation | 2 | $30 |
| Merck Sharp & Dohme LLC | 2 | $30 |
| SCPHARMACEUTICALS INC. | 1 | $26 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $24 |
| Solventum Corporation | 1 | $16 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: CAMZYOS, Repatha, LEQVIO, VERQUVO, FUROSCIX, LifeVest, V.A.C.ULTA, FARXIGA.
Industry payments across MO — which companies pay providers there.
